Department of Neuro-Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, USA.
Curr Opin Ophthalmol. 2020 Nov;31(6):455-461. doi: 10.1097/ICU.0000000000000700.
Optic nerve sheath meningiomas (ONSMs) are rare benign tumors of the anterior visual pathway which present with slowly progressive and painless vision loss and account for approximately 2% of all orbital tumors. This article provides an overview as well as an update on the ONSMs with regards to cause, epidemiology, clinical presentation, diagnosis, and management in adults and pediatric population.
The clinical presentation and prognosis of ONSMs can vary and largely depend on the location of tumor as well as the histologic type. Overall, the diagnosis is based on clinical presentation, examination, and neuroimaging findings. Nevertheless, delays in diagnosis or misdiagnosis are not uncommon and can result in higher morbidity rates. Recent advances in diagnostic as well as more effective and less-invasive treatment options are discussed in this review.
ONSMs are a rare cause of slowly progressive and inexorable visual loss. Although ONSM diagnosis depends on the characteristic clinical and radiologic findings, prompt diagnosis, and appropriate management is critical for favorable visual outcomes. Thus, current focus is optimizing diagnostic as well-treatment methods for patients with ONSMs.
视神经鞘脑膜瘤(ONSMs)是一种罕见的前视觉通路良性肿瘤,表现为缓慢进展性无痛性视力丧失,约占所有眼眶肿瘤的 2%。本文就成人和儿童 ONSMs 的病因、流行病学、临床表现、诊断和治疗进行概述和更新。
ONSMs 的临床表现和预后可能不同,这在很大程度上取决于肿瘤的位置和组织学类型。总的来说,诊断基于临床表现、检查和神经影像学发现。然而,诊断延迟或误诊并不少见,可能导致更高的发病率。本文讨论了诊断以及更有效和微创治疗选择的最新进展。
ONSMs 是一种导致缓慢进行性和不可逆转视力丧失的罕见原因。尽管 ONSM 的诊断取决于特征性的临床和影像学发现,但及时诊断和适当的治疗对于良好的视力结果至关重要。因此,目前的重点是优化 ONSMs 患者的诊断和治疗方法。